Heier Jeffrey S.
Chief Scientific Officer at OCUL
- Sold, on record
- $349k
- Dollars the filings state
- Form 4 sales
- 9
- Latest Aug 24, 2026
- Form 144 notices
- 4
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- OCULOCULAR THERAPEUTIX, INCChief Scientific Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale OCULRoutineMay 23, 2025 2025
Sold 3,024 shares at $7.18 ($22k)
Heier Jeffrey S., Chief Scientific Officer
10b5-1 planSold 1.1% of holdings ($1.9M position)262,974 shares leftFollows a Form 144Filing
- 2 Form 144 notice OCULNoticeAug 25, 2025 +94 days
Filed to sell 3,063 shares ($37k)
Heier Jeffrey S., Officer
No 10b5-1 plan1x usual sizeFiling
- 3 Form 4 sale OCULRoutineAug 25, 2025 same day
Sold 3,063 shares at $12.04 ($37k)
Heier Jeffrey S., Chief Scientific Officer
10b5-1 planSold 1.2% of holdings ($3.2M position)259,911 shares left1x usual sizeFollows a Form 144Filing
- 4 Form 4 sale OCULUnusualOct 2, 2025 +38 days
Sold 10,502 shares at $11.04 ($116k)
Heier Jeffrey S., Chief Scientific Officer
10b5-1 planSold 4% of holdings ($2.9M position)249,409 shares left3.5x usual sizeFiling
- 5 Form 4 sale OCULRoutineNov 24, 2025 +53 days
Sold 3,469 shares at $12.04 ($42k)
Heier Jeffrey S., Chief Scientific Officer
10b5-1 planSold 1.4% of holdings ($3M position)245,940 shares left1.1x usual sizeFiling
- 6 Form 4 sale OCULRoutineFeb 23, 2026 +91 days
Sold 3,057 shares at $8.28 ($25k)
Heier Jeffrey S., Chief Scientific Officer
10b5-1 planSold 0.9% of holdings ($2.7M position)323,368 shares left1x usual sizeFiling
- 7 Form 4 sale OCULRoutineMay 26, 2026 +92 days
Sold 3,018 shares at $8.20 ($25k)
Heier Jeffrey S., Chief Scientific Officer
10b5-1 planSold 0.9% of holdings ($2.7M position)320,350 shares left1x usual sizeFiling
- 8 Form 4 sale OCULRoutineAug 24, 2026 +90 days
Sold 3,296 shares at $10.78 ($36k)
Heier Jeffrey S., Chief Scientific Officer
10b5-1 planSold 1% of holdings ($3.5M position)318,326 shares left1.1x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (13)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Aug 24, 2026 | Aug 26, 2026 | OCUL | Chief Scientific Officer | Form 4 sale | 3,296 | $36k | 1.0% | Routine | SEC |
| May 26, 2026 | May 28, 2026 | OCUL | Chief Scientific Officer | Form 4 sale | 3,018 | $25k | 0.9% | Routine | SEC |
| Feb 23, 2026 | Feb 25, 2026 | OCUL | Chief Scientific Officer | Form 4 sale | 3,057 | $25k | 0.9% | Routine | SEC |
| Nov 24, 2025 | Nov 26, 2025 | OCUL | Chief Scientific Officer | Form 4 sale | 3,469 | $42k | 1.4% | Routine | SEC |
| Oct 2, 2025 | Oct 6, 2025 | OCUL | Chief Scientific Officer | Form 4 sale | 10,502 | $116k | 4.0% | Unusual | SEC |
| Aug 25, 2025 | Aug 27, 2025 | OCUL | Chief Scientific Officer | Form 4 sale | 3,063 | $37k | 1.2% | Routine | SEC |
| Aug 25, 2025 | Aug 25, 2025 | OCUL | Officer | Form 144 notice | 3,063 | $37k | Notice | SEC | |
| May 23, 2025 | May 27, 2025 | OCUL | Chief Scientific Officer | Form 4 sale | 3,024 | $22k | 1.1% | Routine | SEC |
| May 23, 2025 | May 23, 2025 | OCUL | Officer | Form 144 notice | 3,024 | $22k | Notice | SEC | |
| Feb 24, 2025 | Feb 26, 2025 | OCUL | Chief Scientific Officer | Form 4 sale | 3,061 | $21k | 1.1% | Routine | SEC |
| Feb 24, 2025 | Feb 24, 2025 | OCUL | Officer | Form 144 notice | 3,061 | $21k | Notice | SEC | |
| Nov 25, 2024 | Nov 27, 2024 | OCUL | Chief Scientific Officer | Form 4 sale | 2,948 | $27k | 1.1% | Routine | SEC |
| Nov 25, 2024 | Nov 25, 2024 | OCUL | Officer | Form 144 notice | 2,948 | $27k | Notice | SEC |